Diamond Power Infrastructure Limited (DIACABS.BO) Stock Competitors & Peer Comparison
See (DIACABS.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Electrical Equipment & Parts Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DIACABS.BO | ₹231.60 | +6.04% | 118.7B | -225.30 | -₹1.00 | N/A |
| ABB.NS | ₹6,771.50 | -4.26% | 1.5T | 96.20 | ₹72.54 | +0.56% |
| CGPOWER.BO | ₹908.05 | -1.85% | 1.4T | 118.03 | ₹7.71 | +0.14% |
| CGPOWER.NS | ₹908.10 | -1.83% | 1.4T | 117.64 | ₹7.74 | +0.14% |
| POWERINDIA.NS | ₹31,755.00 | -1.87% | 1.4T | 138.38 | ₹230.64 | +0.02% |
| POWERINDIA.BO | ₹31,744.30 | -1.89% | 1.4T | 146.67 | ₹217.35 | +0.02% |
| POLYCAB.BO | ₹9,243.60 | -3.59% | 1.4T | 52.28 | ₹179.93 | +0.50% |
| POLYCAB.NS | ₹9,234.00 | -3.65% | 1.4T | 53.04 | ₹177.24 | +0.50% |
| HAVELLS.NS | ₹1,207.80 | +2.23% | 768.4B | 45.30 | ₹27.04 | +0.82% |
| HAVELLS.BO | ₹1,208.45 | +2.33% | 768.4B | 45.48 | ₹26.93 | +0.82% |
Stock Comparison
DIACABS.BO vs ABB.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, ABB.NS has a market cap of 1.5T. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while ABB.NS trades at ₹6,771.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas ABB.NS's P/E ratio is 96.20. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ABB.NS's ROE of +0.40%. Regarding short-term risk, DIACABS.BO is more volatile compared to ABB.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ABB.NS's competition here
DIACABS.BO vs CGPOWER.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, CGPOWER.BO has a market cap of 1.4T. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while CGPOWER.BO trades at ₹908.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas CGPOWER.BO's P/E ratio is 118.03. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to CGPOWER.BO's ROE of +0.21%. Regarding short-term risk, DIACABS.BO is more volatile compared to CGPOWER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check CGPOWER.BO's competition here
DIACABS.BO vs CGPOWER.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, CGPOWER.NS has a market cap of 1.4T. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while CGPOWER.NS trades at ₹908.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas CGPOWER.NS's P/E ratio is 117.64. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to CGPOWER.NS's ROE of +0.21%. Regarding short-term risk, DIACABS.BO is more volatile compared to CGPOWER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check CGPOWER.NS's competition here
DIACABS.BO vs POWERINDIA.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, POWERINDIA.NS has a market cap of 1.4T. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while POWERINDIA.NS trades at ₹31,755.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas POWERINDIA.NS's P/E ratio is 138.38. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to POWERINDIA.NS's ROE of +0.22%. Regarding short-term risk, DIACABS.BO is more volatile compared to POWERINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check POWERINDIA.NS's competition here
DIACABS.BO vs POWERINDIA.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, POWERINDIA.BO has a market cap of 1.4T. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while POWERINDIA.BO trades at ₹31,744.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas POWERINDIA.BO's P/E ratio is 146.67. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to POWERINDIA.BO's ROE of +0.22%. Regarding short-term risk, DIACABS.BO is more volatile compared to POWERINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check POWERINDIA.BO's competition here
DIACABS.BO vs POLYCAB.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, POLYCAB.BO has a market cap of 1.4T. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while POLYCAB.BO trades at ₹9,243.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas POLYCAB.BO's P/E ratio is 52.28. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to POLYCAB.BO's ROE of +0.24%. Regarding short-term risk, DIACABS.BO is more volatile compared to POLYCAB.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check POLYCAB.BO's competition here
DIACABS.BO vs POLYCAB.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, POLYCAB.NS has a market cap of 1.4T. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while POLYCAB.NS trades at ₹9,234.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas POLYCAB.NS's P/E ratio is 53.04. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to POLYCAB.NS's ROE of +0.24%. Regarding short-term risk, DIACABS.BO is more volatile compared to POLYCAB.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check POLYCAB.NS's competition here
DIACABS.BO vs HAVELLS.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, HAVELLS.NS has a market cap of 768.4B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while HAVELLS.NS trades at ₹1,207.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas HAVELLS.NS's P/E ratio is 45.30. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to HAVELLS.NS's ROE of +0.19%. Regarding short-term risk, DIACABS.BO is more volatile compared to HAVELLS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HAVELLS.NS's competition here
DIACABS.BO vs HAVELLS.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, HAVELLS.BO has a market cap of 768.4B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while HAVELLS.BO trades at ₹1,208.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas HAVELLS.BO's P/E ratio is 45.48. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to HAVELLS.BO's ROE of +0.19%. Regarding short-term risk, DIACABS.BO is more volatile compared to HAVELLS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HAVELLS.BO's competition here
DIACABS.BO vs APARINDS.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, APARINDS.BO has a market cap of 569.5B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while APARINDS.BO trades at ₹13,441.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas APARINDS.BO's P/E ratio is 56.50. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to APARINDS.BO's ROE of +0.20%. Regarding short-term risk, DIACABS.BO is more volatile compared to APARINDS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check APARINDS.BO's competition here
DIACABS.BO vs APARINDS.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, APARINDS.NS has a market cap of 568.6B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while APARINDS.NS trades at ₹13,443.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas APARINDS.NS's P/E ratio is 55.92. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to APARINDS.NS's ROE of +0.20%. Regarding short-term risk, DIACABS.BO is more volatile compared to APARINDS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check APARINDS.NS's competition here
DIACABS.BO vs KEI.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, KEI.NS has a market cap of 488.1B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while KEI.NS trades at ₹5,030.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas KEI.NS's P/E ratio is 53.28. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to KEI.NS's ROE of +0.15%. Regarding short-term risk, DIACABS.BO is more volatile compared to KEI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check KEI.NS's competition here
DIACABS.BO vs KEI.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, KEI.BO has a market cap of 488B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while KEI.BO trades at ₹5,037.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas KEI.BO's P/E ratio is 53.14. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to KEI.BO's ROE of +0.15%. Regarding short-term risk, DIACABS.BO is more volatile compared to KEI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check KEI.BO's competition here
DIACABS.BO vs SCHNEIDER.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, SCHNEIDER.NS has a market cap of 356.9B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while SCHNEIDER.NS trades at ₹1,496.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas SCHNEIDER.NS's P/E ratio is 170.97. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to SCHNEIDER.NS's ROE of +0.32%. Regarding short-term risk, DIACABS.BO is more volatile compared to SCHNEIDER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SCHNEIDER.NS's competition here
DIACABS.BO vs SCHNEIDER.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, SCHNEIDER.BO has a market cap of 356.9B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while SCHNEIDER.BO trades at ₹1,495.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas SCHNEIDER.BO's P/E ratio is 170.39. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to SCHNEIDER.BO's ROE of +0.32%. Regarding short-term risk, DIACABS.BO is more volatile compared to SCHNEIDER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SCHNEIDER.BO's competition here
DIACABS.BO vs HONAUT.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, HONAUT.NS has a market cap of 337.2B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while HONAUT.NS trades at ₹38,045.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas HONAUT.NS's P/E ratio is 59.96. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to HONAUT.NS's ROE of +0.13%. Regarding short-term risk, DIACABS.BO is more volatile compared to HONAUT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HONAUT.NS's competition here
DIACABS.BO vs HONAUT.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, HONAUT.BO has a market cap of 336.4B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while HONAUT.BO trades at ₹38,003.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas HONAUT.BO's P/E ratio is 62.57. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to HONAUT.BO's ROE of +0.13%. Regarding short-term risk, DIACABS.BO is more volatile compared to HONAUT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HONAUT.BO's competition here
DIACABS.BO vs RRKABEL.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, RRKABEL.BO has a market cap of 248B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while RRKABEL.BO trades at ₹2,182.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas RRKABEL.BO's P/E ratio is 49.56. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to RRKABEL.BO's ROE of +0.21%. Regarding short-term risk, DIACABS.BO is more volatile compared to RRKABEL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check RRKABEL.BO's competition here
DIACABS.BO vs RRKABEL.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, RRKABEL.NS has a market cap of 247.8B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while RRKABEL.NS trades at ₹2,188.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas RRKABEL.NS's P/E ratio is 50.24. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to RRKABEL.NS's ROE of +0.21%. Regarding short-term risk, DIACABS.BO is more volatile compared to RRKABEL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check RRKABEL.NS's competition here
DIACABS.BO vs HBLENGINE.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, HBLENGINE.BO has a market cap of 216.9B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while HBLENGINE.BO trades at ₹756.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas HBLENGINE.BO's P/E ratio is 33.94. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to HBLENGINE.BO's ROE of +0.45%. Regarding short-term risk, DIACABS.BO is more volatile compared to HBLENGINE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HBLENGINE.BO's competition here
DIACABS.BO vs HBLENGINE.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, HBLENGINE.NS has a market cap of 216.7B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while HBLENGINE.NS trades at ₹757.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas HBLENGINE.NS's P/E ratio is 33.91. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to HBLENGINE.NS's ROE of +0.43%. Regarding short-term risk, DIACABS.BO is more volatile compared to HBLENGINE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HBLENGINE.NS's competition here
DIACABS.BO vs FINCABLES.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, FINCABLES.NS has a market cap of 160.3B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while FINCABLES.NS trades at ₹1,028.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas FINCABLES.NS's P/E ratio is 25.75. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to FINCABLES.NS's ROE of +0.13%. Regarding short-term risk, DIACABS.BO is more volatile compared to FINCABLES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check FINCABLES.NS's competition here
DIACABS.BO vs FINCABLES.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, FINCABLES.BO has a market cap of 159.8B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while FINCABLES.BO trades at ₹1,029.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas FINCABLES.BO's P/E ratio is 25.69. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to FINCABLES.BO's ROE of +0.13%. Regarding short-term risk, DIACABS.BO is more volatile compared to FINCABLES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check FINCABLES.BO's competition here
DIACABS.BO vs ARE&M.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, ARE&M.NS has a market cap of 154.2B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while ARE&M.NS trades at ₹835.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas ARE&M.NS's P/E ratio is 20.13. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ARE&M.NS's ROE of +0.12%. Regarding short-term risk, DIACABS.BO is more volatile compared to ARE&M.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ARE&M.NS's competition here
DIACABS.BO vs ARE&M.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, ARE&M.BO has a market cap of 153.9B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while ARE&M.BO trades at ₹834.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas ARE&M.BO's P/E ratio is 20.66. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ARE&M.BO's ROE of +0.12%. Regarding short-term risk, DIACABS.BO is more volatile compared to ARE&M.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ARE&M.BO's competition here
DIACABS.BO vs HBLPOWER.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, HBLPOWER.NS has a market cap of 136.5B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while HBLPOWER.NS trades at ₹492.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas HBLPOWER.NS's P/E ratio is 41.92. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to HBLPOWER.NS's ROE of +0.43%. Regarding short-term risk, DIACABS.BO is more volatile compared to HBLPOWER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HBLPOWER.NS's competition here
DIACABS.BO vs HBLPOWER.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, HBLPOWER.BO has a market cap of 136.5B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while HBLPOWER.BO trades at ₹492.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas HBLPOWER.BO's P/E ratio is 41.96. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to HBLPOWER.BO's ROE of +0.43%. Regarding short-term risk, DIACABS.BO is more volatile compared to HBLPOWER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HBLPOWER.BO's competition here
DIACABS.BO vs VGUARD.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, VGUARD.NS has a market cap of 133.1B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while VGUARD.NS trades at ₹302.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas VGUARD.NS's P/E ratio is 40.09. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to VGUARD.NS's ROE of +0.14%. Regarding short-term risk, DIACABS.BO is more volatile compared to VGUARD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check VGUARD.NS's competition here
DIACABS.BO vs VGUARD.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, VGUARD.BO has a market cap of 133.1B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while VGUARD.BO trades at ₹302.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas VGUARD.BO's P/E ratio is 40.29. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to VGUARD.BO's ROE of +0.14%. Regarding short-term risk, DIACABS.BO is more volatile compared to VGUARD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check VGUARD.BO's competition here
DIACABS.BO vs DIACABS.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, DIACABS.NS has a market cap of 118.5B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while DIACABS.NS trades at ₹231.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas DIACABS.NS's P/E ratio is 75.23. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to DIACABS.NS's ROE of -0.21%. Regarding short-term risk, DIACABS.BO is less volatile compared to DIACABS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check DIACABS.NS's competition here
DIACABS.BO vs GRAPHITE.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, GRAPHITE.BO has a market cap of 117.9B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while GRAPHITE.BO trades at ₹579.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas GRAPHITE.BO's P/E ratio is 61.77. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to GRAPHITE.BO's ROE of +0.03%. Regarding short-term risk, DIACABS.BO is more volatile compared to GRAPHITE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check GRAPHITE.BO's competition here
DIACABS.BO vs GRAPHITE.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, GRAPHITE.NS has a market cap of 117.9B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while GRAPHITE.NS trades at ₹579.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas GRAPHITE.NS's P/E ratio is 61.74. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to GRAPHITE.NS's ROE of +0.03%. Regarding short-term risk, DIACABS.BO is more volatile compared to GRAPHITE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check GRAPHITE.NS's competition here
DIACABS.BO vs TRIL.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, TRIL.BO has a market cap of 112B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while TRIL.BO trades at ₹745.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas TRIL.BO's P/E ratio is 133.44. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to TRIL.BO's ROE of +0.09%. Regarding short-term risk, DIACABS.BO is more volatile compared to TRIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check TRIL.BO's competition here
DIACABS.BO vs TRIL.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, TRIL.NS has a market cap of 111.9B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while TRIL.NS trades at ₹745.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas TRIL.NS's P/E ratio is 134.05. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to TRIL.NS's ROE of +0.09%. Regarding short-term risk, DIACABS.BO is more volatile compared to TRIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check TRIL.NS's competition here
DIACABS.BO vs AMARAJABAT.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, AMARAJABAT.NS has a market cap of 103.2B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while AMARAJABAT.NS trades at ₹604.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas AMARAJABAT.NS's P/E ratio is 13.68. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to AMARAJABAT.NS's ROE of +0.14%. Regarding short-term risk, DIACABS.BO is more volatile compared to AMARAJABAT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check AMARAJABAT.NS's competition here
DIACABS.BO vs HEG.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, HEG.NS has a market cap of 102.5B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while HEG.NS trades at ₹526.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas HEG.NS's P/E ratio is 32.54. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to HEG.NS's ROE of +0.07%. Regarding short-term risk, DIACABS.BO is more volatile compared to HEG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HEG.NS's competition here
DIACABS.BO vs TARIL.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, TARIL.NS has a market cap of 100.2B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while TARIL.NS trades at ₹322.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas TARIL.NS's P/E ratio is 31.98. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to TARIL.NS's ROE of +0.19%. Regarding short-term risk, DIACABS.BO is more volatile compared to TARIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check TARIL.NS's competition here
DIACABS.BO vs VOLTAMP.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, VOLTAMP.NS has a market cap of 98.2B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while VOLTAMP.NS trades at ₹9,390.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas VOLTAMP.NS's P/E ratio is 63.63. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to VOLTAMP.NS's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is more volatile compared to VOLTAMP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check VOLTAMP.NS's competition here
DIACABS.BO vs VOLTAMP.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, VOLTAMP.BO has a market cap of 98.1B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while VOLTAMP.BO trades at ₹9,380.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas VOLTAMP.BO's P/E ratio is 31.55. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to VOLTAMP.BO's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is more volatile compared to VOLTAMP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check VOLTAMP.BO's competition here
DIACABS.BO vs ESABINDIA.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, ESABINDIA.BO has a market cap of 87.9B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while ESABINDIA.BO trades at ₹5,652.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas ESABINDIA.BO's P/E ratio is 50.29. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ESABINDIA.BO's ROE of +0.53%. Regarding short-term risk, DIACABS.BO is more volatile compared to ESABINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ESABINDIA.BO's competition here
DIACABS.BO vs ESABINDIA.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, ESABINDIA.NS has a market cap of 87.7B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while ESABINDIA.NS trades at ₹5,662.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas ESABINDIA.NS's P/E ratio is 50.26. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ESABINDIA.NS's ROE of +0.53%. Regarding short-term risk, DIACABS.BO is more volatile compared to ESABINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ESABINDIA.NS's competition here
DIACABS.BO vs QPOWER.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, QPOWER.NS has a market cap of 85.9B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while QPOWER.NS trades at ₹1,099.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas QPOWER.NS's P/E ratio is 117.85. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to QPOWER.NS's ROE of +0.24%. Regarding short-term risk, DIACABS.BO is more volatile compared to QPOWER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check QPOWER.NS's competition here
DIACABS.BO vs GENUSPOWER.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, GENUSPOWER.BO has a market cap of 85.7B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while GENUSPOWER.BO trades at ₹301.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas GENUSPOWER.BO's P/E ratio is 14.88. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to GENUSPOWER.BO's ROE of +0.30%. Regarding short-term risk, DIACABS.BO is more volatile compared to GENUSPOWER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check GENUSPOWER.BO's competition here
DIACABS.BO vs GENUSPOWER.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, GENUSPOWER.NS has a market cap of 85.6B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while GENUSPOWER.NS trades at ₹301.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas GENUSPOWER.NS's P/E ratio is 15.34. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to GENUSPOWER.NS's ROE of +0.30%. Regarding short-term risk, DIACABS.BO is more volatile compared to GENUSPOWER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check GENUSPOWER.NS's competition here
DIACABS.BO vs QPOWER.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, QPOWER.BO has a market cap of 70.5B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while QPOWER.BO trades at ₹909.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas QPOWER.BO's P/E ratio is 180.85. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to QPOWER.BO's ROE of +0.24%. Regarding short-term risk, DIACABS.BO is more volatile compared to QPOWER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check QPOWER.BO's competition here
DIACABS.BO vs PRECWIRE.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, PRECWIRE.NS has a market cap of 68.4B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while PRECWIRE.NS trades at ₹374.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas PRECWIRE.NS's P/E ratio is 43.53. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to PRECWIRE.NS's ROE of +0.24%. Regarding short-term risk, DIACABS.BO is more volatile compared to PRECWIRE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check PRECWIRE.NS's competition here
DIACABS.BO vs PRECWIRE.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, PRECWIRE.BO has a market cap of 67.7B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while PRECWIRE.BO trades at ₹376.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas PRECWIRE.BO's P/E ratio is 43.52. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to PRECWIRE.BO's ROE of +0.24%. Regarding short-term risk, DIACABS.BO is more volatile compared to PRECWIRE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check PRECWIRE.BO's competition here
DIACABS.BO vs SHILCTECH.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, SHILCTECH.BO has a market cap of 49.2B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while SHILCTECH.BO trades at ₹4,239.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas SHILCTECH.BO's P/E ratio is 48.13. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to SHILCTECH.BO's ROE of +0.39%. Regarding short-term risk, DIACABS.BO is more volatile compared to SHILCTECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SHILCTECH.BO's competition here
DIACABS.BO vs VMARCIND.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, VMARCIND.NS has a market cap of 42.5B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while VMARCIND.NS trades at ₹273.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas VMARCIND.NS's P/E ratio is 11.72. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to VMARCIND.NS's ROE of N/A. Regarding short-term risk, DIACABS.BO is less volatile compared to VMARCIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check VMARCIND.NS's competition here
DIACABS.BO vs UNIVCABLES.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, UNIVCABLES.NS has a market cap of 38.5B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while UNIVCABLES.NS trades at ₹1,081.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas UNIVCABLES.NS's P/E ratio is 23.32. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to UNIVCABLES.NS's ROE of +0.09%. Regarding short-term risk, DIACABS.BO is more volatile compared to UNIVCABLES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check UNIVCABLES.NS's competition here
DIACABS.BO vs UNIVCABLES.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, UNIVCABLES.BO has a market cap of 38.5B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while UNIVCABLES.BO trades at ₹1,082.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas UNIVCABLES.BO's P/E ratio is 23.62. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to UNIVCABLES.BO's ROE of +0.09%. Regarding short-term risk, DIACABS.BO is more volatile compared to UNIVCABLES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check UNIVCABLES.BO's competition here
DIACABS.BO vs RAMRAT.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, RAMRAT.BO has a market cap of 37.8B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while RAMRAT.BO trades at ₹413.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas RAMRAT.BO's P/E ratio is 35.28. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to RAMRAT.BO's ROE of +0.21%. Regarding short-term risk, DIACABS.BO is more volatile compared to RAMRAT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check RAMRAT.BO's competition here
DIACABS.BO vs RAMRAT.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, RAMRAT.NS has a market cap of 37.7B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while RAMRAT.NS trades at ₹412.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas RAMRAT.NS's P/E ratio is 35.26. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to RAMRAT.NS's ROE of +0.21%. Regarding short-term risk, DIACABS.BO is more volatile compared to RAMRAT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check RAMRAT.NS's competition here
DIACABS.BO vs HIRECT.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, HIRECT.NS has a market cap of 36.4B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while HIRECT.NS trades at ₹1,025.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas HIRECT.NS's P/E ratio is 50.15. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to HIRECT.NS's ROE of +0.25%. Regarding short-term risk, DIACABS.BO is more volatile compared to HIRECT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HIRECT.NS's competition here
DIACABS.BO vs HIRECT.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, HIRECT.BO has a market cap of 36.3B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while HIRECT.BO trades at ₹1,028.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas HIRECT.BO's P/E ratio is 80.63. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to HIRECT.BO's ROE of +0.25%. Regarding short-term risk, DIACABS.BO is more volatile compared to HIRECT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HIRECT.BO's competition here
DIACABS.BO vs MARINE.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, MARINE.NS has a market cap of 33.7B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while MARINE.NS trades at ₹247.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas MARINE.NS's P/E ratio is 60.68. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to MARINE.NS's ROE of +0.13%. Regarding short-term risk, DIACABS.BO is more volatile compared to MARINE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check MARINE.NS's competition here
DIACABS.BO vs INDOTECH.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, INDOTECH.BO has a market cap of 32.8B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while INDOTECH.BO trades at ₹3,069.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas INDOTECH.BO's P/E ratio is 35.22. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to INDOTECH.BO's ROE of +0.29%. Regarding short-term risk, DIACABS.BO is more volatile compared to INDOTECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check INDOTECH.BO's competition here
DIACABS.BO vs INDOTECH.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, INDOTECH.NS has a market cap of 32.4B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while INDOTECH.NS trades at ₹3,088.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas INDOTECH.NS's P/E ratio is 34.90. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to INDOTECH.NS's ROE of +0.29%. Regarding short-term risk, DIACABS.BO is more volatile compared to INDOTECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check INDOTECH.NS's competition here
DIACABS.BO vs BBL.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, BBL.NS has a market cap of 30.6B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while BBL.NS trades at ₹2,641.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas BBL.NS's P/E ratio is 19.75. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to BBL.NS's ROE of +0.06%. Regarding short-term risk, DIACABS.BO is more volatile compared to BBL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check BBL.NS's competition here
DIACABS.BO vs SPECTRUM.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, SPECTRUM.NS has a market cap of 30.6B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while SPECTRUM.NS trades at ₹1,875.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas SPECTRUM.NS's P/E ratio is 77.04. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to SPECTRUM.NS's ROE of +0.23%. Regarding short-term risk, DIACABS.BO is more volatile compared to SPECTRUM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SPECTRUM.NS's competition here
DIACABS.BO vs BBL.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, BBL.BO has a market cap of 30.6B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while BBL.BO trades at ₹2,645.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas BBL.BO's P/E ratio is 25.48. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to BBL.BO's ROE of +0.06%. Regarding short-term risk, DIACABS.BO is more volatile compared to BBL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check BBL.BO's competition here
DIACABS.BO vs EVEREADY.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, EVEREADY.NS has a market cap of 26.6B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while EVEREADY.NS trades at ₹352.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas EVEREADY.NS's P/E ratio is 15.53. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to EVEREADY.NS's ROE of +0.34%. Regarding short-term risk, DIACABS.BO is more volatile compared to EVEREADY.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check EVEREADY.NS's competition here
DIACABS.BO vs EVEREADY.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, EVEREADY.BO has a market cap of 26.6B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while EVEREADY.BO trades at ₹351.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas EVEREADY.BO's P/E ratio is 15.52. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to EVEREADY.BO's ROE of +0.34%. Regarding short-term risk, DIACABS.BO is more volatile compared to EVEREADY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check EVEREADY.BO's competition here
DIACABS.BO vs RISHABH.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, RISHABH.BO has a market cap of 24.3B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while RISHABH.BO trades at ₹649.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas RISHABH.BO's P/E ratio is 317.93. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to RISHABH.BO's ROE of +0.12%. Regarding short-term risk, DIACABS.BO is more volatile compared to RISHABH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check RISHABH.BO's competition here
DIACABS.BO vs MODINSU.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, MODINSU.BO has a market cap of 24.1B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while MODINSU.BO trades at ₹497.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas MODINSU.BO's P/E ratio is 124.78. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to MODINSU.BO's ROE of +0.16%. Regarding short-term risk, DIACABS.BO is more volatile compared to MODINSU.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check MODINSU.BO's competition here
DIACABS.BO vs EXICOM.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, EXICOM.NS has a market cap of 22.8B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while EXICOM.NS trades at ₹158.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas EXICOM.NS's P/E ratio is -8.05. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to EXICOM.NS's ROE of -0.42%. Regarding short-term risk, DIACABS.BO is more volatile compared to EXICOM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check EXICOM.NS's competition here
DIACABS.BO vs SERVOTECH.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, SERVOTECH.NS has a market cap of 22.6B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while SERVOTECH.NS trades at ₹95.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas SERVOTECH.NS's P/E ratio is 62.47. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to SERVOTECH.NS's ROE of +0.13%. Regarding short-term risk, DIACABS.BO is more volatile compared to SERVOTECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SERVOTECH.NS's competition here
DIACABS.BO vs EXICOM.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, EXICOM.BO has a market cap of 22.5B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while EXICOM.BO trades at ₹158.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas EXICOM.BO's P/E ratio is -7.94. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to EXICOM.BO's ROE of -0.42%. Regarding short-term risk, DIACABS.BO is more volatile compared to EXICOM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check EXICOM.BO's competition here
DIACABS.BO vs HPL.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, HPL.BO has a market cap of 22.1B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while HPL.BO trades at ₹340.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas HPL.BO's P/E ratio is 20.37. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to HPL.BO's ROE of +0.10%. Regarding short-term risk, DIACABS.BO is more volatile compared to HPL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HPL.BO's competition here
DIACABS.BO vs HPL.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, HPL.NS has a market cap of 22.1B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while HPL.NS trades at ₹338.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas HPL.NS's P/E ratio is 20.36. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to HPL.NS's ROE of +0.10%. Regarding short-term risk, DIACABS.BO is more volatile compared to HPL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HPL.NS's competition here
DIACABS.BO vs MARSONS.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, MARSONS.BO has a market cap of 19.4B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while MARSONS.BO trades at ₹105.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas MARSONS.BO's P/E ratio is 287.77. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to MARSONS.BO's ROE of +0.31%. Regarding short-term risk, DIACABS.BO is more volatile compared to MARSONS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check MARSONS.BO's competition here
DIACABS.BO vs DYCL.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, DYCL.BO has a market cap of 17.2B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while DYCL.BO trades at ₹350.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas DYCL.BO's P/E ratio is 104.06. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to DYCL.BO's ROE of +0.00%. Regarding short-term risk, DIACABS.BO is more volatile compared to DYCL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check DYCL.BO's competition here
DIACABS.BO vs DYCL.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, DYCL.NS has a market cap of 17.2B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while DYCL.NS trades at ₹350.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas DYCL.NS's P/E ratio is 20.33. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to DYCL.NS's ROE of +0.21%. Regarding short-term risk, DIACABS.BO is less volatile compared to DYCL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check DYCL.NS's competition here
DIACABS.BO vs IKIO.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, IKIO.NS has a market cap of 14.7B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while IKIO.NS trades at ₹181.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas IKIO.NS's P/E ratio is 38.50. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to IKIO.NS's ROE of +0.07%. Regarding short-term risk, DIACABS.BO is more volatile compared to IKIO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check IKIO.NS's competition here
DIACABS.BO vs IKIO.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, IKIO.BO has a market cap of 14.5B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while IKIO.BO trades at ₹182.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas IKIO.BO's P/E ratio is 38.05. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to IKIO.BO's ROE of +0.07%. Regarding short-term risk, DIACABS.BO is more volatile compared to IKIO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check IKIO.BO's competition here
DIACABS.BO vs DPEL.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, DPEL.NS has a market cap of 12B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while DPEL.NS trades at ₹556.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas DPEL.NS's P/E ratio is 123.43. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to DPEL.NS's ROE of N/A. Regarding short-term risk, DIACABS.BO is more volatile compared to DPEL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check DPEL.NS's competition here
DIACABS.BO vs SALZERELEC.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, SALZERELEC.BO has a market cap of 11B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while SALZERELEC.BO trades at ₹601.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas SALZERELEC.BO's P/E ratio is 25.73. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to SALZERELEC.BO's ROE of +0.09%. Regarding short-term risk, DIACABS.BO is more volatile compared to SALZERELEC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SALZERELEC.BO's competition here
DIACABS.BO vs SALZERELEC.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, SALZERELEC.NS has a market cap of 10.9B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while SALZERELEC.NS trades at ₹597.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas SALZERELEC.NS's P/E ratio is 23.48. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to SALZERELEC.NS's ROE of +0.09%. Regarding short-term risk, DIACABS.BO is more volatile compared to SALZERELEC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SALZERELEC.NS's competition here
DIACABS.BO vs MODISONLTD.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, MODISONLTD.BO has a market cap of 9.6B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while MODISONLTD.BO trades at ₹286.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas MODISONLTD.BO's P/E ratio is 13.20. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to MODISONLTD.BO's ROE of +0.31%. Regarding short-term risk, DIACABS.BO is more volatile compared to MODISONLTD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check MODISONLTD.BO's competition here
DIACABS.BO vs MODISONLTD.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, MODISONLTD.NS has a market cap of 9.5B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while MODISONLTD.NS trades at ₹286.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas MODISONLTD.NS's P/E ratio is 12.36. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to MODISONLTD.NS's ROE of +0.31%. Regarding short-term risk, DIACABS.BO is more volatile compared to MODISONLTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check MODISONLTD.NS's competition here
DIACABS.BO vs HUIL.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, HUIL.BO has a market cap of 9.3B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while HUIL.BO trades at ₹1,284.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas HUIL.BO's P/E ratio is -34.50. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to HUIL.BO's ROE of -0.06%. Regarding short-term risk, DIACABS.BO is more volatile compared to HUIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HUIL.BO's competition here
DIACABS.BO vs MEIL.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, MEIL.NS has a market cap of 8.5B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while MEIL.NS trades at ₹297.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas MEIL.NS's P/E ratio is 17.64. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to MEIL.NS's ROE of +0.10%. Regarding short-term risk, DIACABS.BO is more volatile compared to MEIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check MEIL.NS's competition here
DIACABS.BO vs PROSTARM.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, PROSTARM.NS has a market cap of 8B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while PROSTARM.NS trades at ₹133.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas PROSTARM.NS's P/E ratio is 23.18. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to PROSTARM.NS's ROE of +0.15%. Regarding short-term risk, DIACABS.BO is more volatile compared to PROSTARM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check PROSTARM.NS's competition here
DIACABS.BO vs SALZER.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, SALZER.BO has a market cap of 7.1B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while SALZER.BO trades at ₹444.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas SALZER.BO's P/E ratio is 32.64. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to SALZER.BO's ROE of +0.02%. Regarding short-term risk, DIACABS.BO is more volatile compared to SALZER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SALZER.BO's competition here
DIACABS.BO vs SUPREMEPWR.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, SUPREMEPWR.NS has a market cap of 5.6B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while SUPREMEPWR.NS trades at ₹215.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas SUPREMEPWR.NS's P/E ratio is 27.07. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to SUPREMEPWR.NS's ROE of N/A. Regarding short-term risk, DIACABS.BO is more volatile compared to SUPREMEPWR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SUPREMEPWR.NS's competition here
DIACABS.BO vs SAAKSHI.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, SAAKSHI.NS has a market cap of 5.2B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while SAAKSHI.NS trades at ₹295.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas SAAKSHI.NS's P/E ratio is 111.47. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to SAAKSHI.NS's ROE of N/A. Regarding short-term risk, DIACABS.BO is more volatile compared to SAAKSHI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SAAKSHI.NS's competition here
DIACABS.BO vs HIGHENE.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, HIGHENE.BO has a market cap of 5.1B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while HIGHENE.BO trades at ₹557.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas HIGHENE.BO's P/E ratio is 44.03. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to HIGHENE.BO's ROE of +0.15%. Regarding short-term risk, DIACABS.BO is more volatile compared to HIGHENE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HIGHENE.BO's competition here
DIACABS.BO vs ELIN.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, ELIN.NS has a market cap of 5B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while ELIN.NS trades at ₹97.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas ELIN.NS's P/E ratio is 21.74. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ELIN.NS's ROE of +0.04%. Regarding short-term risk, DIACABS.BO is more volatile compared to ELIN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ELIN.NS's competition here
DIACABS.BO vs ELIN.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, ELIN.BO has a market cap of 5B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while ELIN.BO trades at ₹96.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas ELIN.BO's P/E ratio is 21.73. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to ELIN.BO's ROE of +0.04%. Regarding short-term risk, DIACABS.BO is more volatile compared to ELIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ELIN.BO's competition here
DIACABS.BO vs DENORA.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, DENORA.NS has a market cap of 4.8B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while DENORA.NS trades at ₹848.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas DENORA.NS's P/E ratio is 53.53. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to DENORA.NS's ROE of +0.07%. Regarding short-term risk, DIACABS.BO is less volatile compared to DENORA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check DENORA.NS's competition here
DIACABS.BO vs DENORA.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, DENORA.BO has a market cap of 4.8B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while DENORA.BO trades at ₹843.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas DENORA.BO's P/E ratio is 53.42. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to DENORA.BO's ROE of +0.07%. Regarding short-term risk, DIACABS.BO is less volatile compared to DENORA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check DENORA.BO's competition here
DIACABS.BO vs S&SPOWER.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, S&SPOWER.NS has a market cap of 4.4B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while S&SPOWER.NS trades at ₹358.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas S&SPOWER.NS's P/E ratio is 4849.58. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to S&SPOWER.NS's ROE of +0.13%. Regarding short-term risk, DIACABS.BO is more volatile compared to S&SPOWER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check S&SPOWER.NS's competition here
DIACABS.BO vs AEPL.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, AEPL.BO has a market cap of 4.3B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while AEPL.BO trades at ₹16.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas AEPL.BO's P/E ratio is 82.60. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to AEPL.BO's ROE of +0.10%. Regarding short-term risk, DIACABS.BO is more volatile compared to AEPL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check AEPL.BO's competition here
DIACABS.BO vs WSI.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, WSI.NS has a market cap of 4.2B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while WSI.NS trades at ₹62.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas WSI.NS's P/E ratio is 10.48. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to WSI.NS's ROE of +0.01%. Regarding short-term risk, DIACABS.BO is more volatile compared to WSI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check WSI.NS's competition here
DIACABS.BO vs SHERA.NS Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, SHERA.NS has a market cap of 3.7B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while SHERA.NS trades at ₹145.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas SHERA.NS's P/E ratio is 19.62. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to SHERA.NS's ROE of N/A. Regarding short-term risk, DIACABS.BO is more volatile compared to SHERA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SHERA.NS's competition here
DIACABS.BO vs DLTNCBL.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, DLTNCBL.BO has a market cap of 3.6B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while DLTNCBL.BO trades at ₹407.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas DLTNCBL.BO's P/E ratio is 43.38. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to DLTNCBL.BO's ROE of +0.09%. Regarding short-term risk, DIACABS.BO is more volatile compared to DLTNCBL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check DLTNCBL.BO's competition here
DIACABS.BO vs WSIND.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, WSIND.BO has a market cap of 3.5B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while WSIND.BO trades at ₹131.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas WSIND.BO's P/E ratio is -6.02. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to WSIND.BO's ROE of +0.01%. Regarding short-term risk, DIACABS.BO is less volatile compared to WSIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check WSIND.BO's competition here
DIACABS.BO vs COSPOWER.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, COSPOWER.BO has a market cap of 3.3B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while COSPOWER.BO trades at ₹1,800.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas COSPOWER.BO's P/E ratio is 23.49. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to COSPOWER.BO's ROE of +0.38%. Regarding short-term risk, DIACABS.BO is more volatile compared to COSPOWER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check COSPOWER.BO's competition here
DIACABS.BO vs RMC.BO Comparison July 2026
DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.BO stands at 118.7B. In comparison, RMC.BO has a market cap of 3.1B. Regarding current trading prices, DIACABS.BO is priced at ₹231.60, while RMC.BO trades at ₹293.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.BO currently has a P/E ratio of -225.30, whereas RMC.BO's P/E ratio is 14.05. In terms of profitability, DIACABS.BO's ROE is -0.21%, compared to RMC.BO's ROE of +0.22%. Regarding short-term risk, DIACABS.BO is more volatile compared to RMC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check RMC.BO's competition here